Condor Capital Management Bristol Myers Squibb CO Transaction History

Condor Capital Management

$1.03 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	BUY	$57.89 - $64.73 $6,541 - $7,314	113 Added 2.94%	3,963 $230,000
Q2 2023 Aug 10, 2023	BUY	$63.71 - $70.74 $245,283 - $272,349	3,850 New	3,850 $246,000
Q4 2022 Feb 07, 2023	BUY	$68.48 - $81.09 $3,971 - $4,703	58 Added 1.36%	4,318 $310,000
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $3,831 - $2.26 Million	-29,475 Reduced 87.37%	4,260 $303,000
Q2 2022 Aug 09, 2022	SELL	$72.62 - $79.98 $11,546 - $12,716	-159 Reduced 0.47%	33,735 $2.6 Million
Q1 2022 May 10, 2022	BUY	$61.48 - $73.72 $86,625 - $103,871	1,409 Added 4.34%	33,894 $2.48 Million
Q4 2021 Feb 09, 2022	SELL	$53.63 - $62.52 $1.17 Million - $1.37 Million	-21,904 Reduced 40.27%	32,485 $2.03 Million
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $47,276 - $55,378	-799 Reduced 1.45%	54,389 $3.22 Million
Q2 2021 Aug 11, 2021	BUY	$61.91 - $67.42 $9,224 - $10,045	149 Added 0.27%	55,188 $3.69 Million
Q1 2021 May 10, 2021	BUY	$59.34 - $66.74 $5,518 - $6,206	93 Added 0.17%	55,039 $3.48 Million
Q4 2020 Jan 29, 2021	BUY	$57.74 - $65.43 $20,497 - $23,227	355 Added 0.65%	54,946 $3.41 Million
Q3 2020 Nov 09, 2020	BUY	$57.43 - $63.64 $411,887 - $456,426	7,172 Added 15.12%	54,591 $3.29 Million
Q2 2020 Aug 07, 2020	BUY	$54.82 - $64.09 $30,425 - $35,569	555 Added 1.18%	47,419 $2.79 Million
Q1 2020 May 07, 2020	BUY	$46.4 - $67.43 $385,120 - $559,669	8,300 Added 21.52%	46,864 $2.61 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $475,171 - $619,818	9,656 Added 33.4%	38,564 $2.48 Million
Q3 2019 Nov 06, 2019	SELL	$42.77 - $50.71 $51,238 - $60,750	-1,198 Reduced 3.98%	28,908 $1.47 Million
Q2 2019 Aug 05, 2019	BUY	$44.62 - $49.34 $3,346 - $3,700	75 Added 0.25%	30,106 $1.37 Million
Q1 2019 May 01, 2019	SELL	$45.12 - $53.8 $2,571 - $3,066	-57 Reduced 0.19%	30,031 $1.43 Million
Q4 2018 Feb 08, 2019	SELL	$48.76 - $63.23 $14,628 - $18,969	-300 Reduced 0.99%	30,088 $1.56 Million
Q2 2018 Aug 01, 2018	BUY	$50.53 - $62.98 $25,265 - $31,490	500 Added 1.67%	30,388 $1.68 Million
Q1 2018 May 04, 2018	SELL	$59.92 - $68.98 $28,761 - $33,110	-480 Reduced 1.58%	29,888 $1.89 Million
Q4 2017 Feb 08, 2018	BUY	$59.94 - $65.35 $28,771 - $31,367	480 Added 1.61%	30,368 $1.86 Million
Q3 2017 Nov 08, 2017	BUY	$55.23 - $63.74 $1.65 Million - $1.91 Million	29,888	29,888 $1.91 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Condor Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Condor Capital Management with notifications on news.

Account